Last week, the Research Institute in Primary Healthcare IDIAPJGol and the Catalan Institute of Health (ICS) presented their Annual Awards for "Research in Primary Health Care IDIAPJGol-ICS". A total of 23 researchers were awarded in different categories.
European Commission proposes a unified market for medicines and incentives for antibiotic development to address drug shortages in EU
The European Commission has recently put forth a proposal to amend the EU pharmaceutical legislation on April 26, 2023 (available at https://health.ec.europa.eu/system/files/2023-04/com_2023_193_1_act_en.pdf). This proposed revision aims to establish a unified market for medicines across all EU member states, thereby promoting greater accessibility to novel and effective drugs while also tackling...
WHO warns of too few new drugs for deadly superbugs
The WHO has called on governments and pharmaceutical companies to invest in research and development of new antibiotics and has also recommended that antibiotics be used more judiciously to prevent the emergence of drug-resistant bacteria.
Spain becomes a benchmark in Europe in the fight against antimicrobial resistance thanks to PROA certification standard
Global increase in antimicrobial resistance and complexity of infectious disease make it essential to establish Antimicrobial Use Optimization Programs (PROA) in the community and hospital areas. These programs have the objective of optimizing prescription of antibiotics, guaranteeing optimal clinical results, minimizing adverse effects derived from their use, controlling the appearance...
More than 400 European experts
participate in the project HAPPY PATIENT
to optimize the use of antibiotics
• One of the research lines of the HAPPY PATIENT European project is to develop a strategy to improve communication between professionals and patients. • As the celebration of the European Day for the Prudent Use of Antibiotics approaches on November 18, it is worth remembering that the adequacy of...
WHO IS WHO in HAPPY PATIENT: University of Groningen – RUG
The Department of PharmacoTherapy -Epidemiology and Economics of the University of Groningen (The Netherlands) is responsible for WP6 which is leading the Audit cycles in community pharmacies and adapting the APO Templates to pharmacies in the Target Countries. The members who are participating in the HAPPY PATIENT project come from very different...